Cary Linsky, the recently retired director of medical affairs for Ethicon, a Johnson & Johnson company, will be the featured speaker at the inaugural meeting of the Southeastern Medical Device Association (SEMDA).
Linsky, who has been an expert in the medical device industry for the past 33 years, will discuss “Clinical Diligence in Emerging Companies,” at the SEMDA meeting March 31.
“There is a critical need for organizations such as SEMDA,” Linsky says. “It should be an excellent resource for information on topics such as product development, clinical studies, and regulatory approval. SEMDA should also be useful in helping emerging companies and individuals with new devices gain the attention of medical device marketers.”
During the past 13 years, Linsky has been involved in clinical research in support of business development and new product development initiatives at Ethicon. He has been responsible for planning, conducting and evaluating clinical research on prospective acquisition targets.
Linsky also has product development experience, primarily with implantable devices. He has been awarded five patents, including those covering the first approved adhesion prevention device (Interceed). The FDA recognized Interceed as one of the nine most significant advances in medical technology in the year it was approved.
“We’re extremely lucky to have someone with Dr. Linsky’s skills to kick off our first meeting,” says SEMDA President Rick Haury, a partner in the healthcare group of law firm Morris, Manning & Martin in Atlanta.
SEMDA will hold its inaugural meeting at the Buckhead Club on the 18th floor of the Atlanta Financial Center. Networking begins at 5:30 PM followed by the program at 6:00.
Morris, Manning & Martin: www.mmlaw.com
